Skip to main content
. 2015 Oct 28;20:367–373. doi: 10.1007/s11605-015-2995-9

Fig. 1.

Fig. 1

PIPAC is well tolerated. Although the dose applied is only 10 % of a usual systemic dose, patients develop a postoperative inflammatory syndrome with elevated C-reactive protein, probably explained by a chemical peritonitis. However, acute and cumulative local toxicities of PIPAC are well controlled and no bowel perforation and no gastrointestinal side effects > CTCAE grade 2 were observed